| 8.39 0.11 (1.33%) | 12-08 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 9.92  |
1-year : | 11.59 |
| Resists | First : | 8.5 |
Second : | 9.92 |
| Pivot price | 7.48 |
|||
| Supports | First : | 7.07 |
Second : | 6.19 |
| MAs | MA(5) : | 8.17 |
MA(20) : | 7.41 |
| MA(100) : | 5.58 |
MA(250) : | 3.55 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 88.6 |
D(3) : | 86.6 |
| RSI | RSI(14): 70.9 |
|||
| 52-week | High : | 8.5 | Low : | 1.13 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ LFMD ] has closed below upper band by 9.8%. Bollinger Bands are 49.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 8.51 - 8.54 | 8.54 - 8.58 |
| Low: | 8.09 - 8.12 | 8.12 - 8.16 |
| Close: | 8.32 - 8.38 | 8.38 - 8.45 |
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Thu, 07 Dec 2023
Where Does LifeMD Inc (LFMD) Stock Fall in the Pharmaceutical Retailers Field After It Is Higher By 3.90% This Week? - InvestorsObserver
Sun, 03 Dec 2023
Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying? - Simply Wall St
Thu, 30 Nov 2023
Will LifeMD Inc (LFMD) Beat the Rest of the Stocks in the Consumer Defensive Sector? - InvestorsObserver
Mon, 27 Nov 2023
LifeMD Inc (LFMD) has fallen -6.53% in a Week, Should You Hold? - InvestorsObserver
Sun, 26 Nov 2023
LifeMD: My Tech Pick For 2024 And Its 12% Yielding Preferreds (NASDAQ:LFMD) - Seeking Alpha
Sun, 26 Nov 2023
LifeMD, Inc. (NASDAQ:LFMD) most popular amongst retail investors who own 50% of the shares, institutions hold 21% - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Pharmaceutical Retailers
|
|
| Shares Out | 38 (M) |
| Shares Float | 27 (M) |
| Held by Insiders | 23.4 (%) |
| Held by Institutions | 17 (%) |
| Shares Short | 2,480 (K) |
| Shares Short P.Month | 2,450 (K) |
| EPS | -0.99 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.38 |
| Profit Margin | -21.3 % |
| Operating Margin | -11.9 % |
| Return on Assets (ttm) | -32.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 22.8 % |
| Gross Profit (p.s.) | 2.64 |
| Sales Per Share | 3.57 |
| EBITDA (p.s.) | -0.43 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -8.57 |
| PEG Ratio | 0 |
| Price to Book value | -22.68 |
| Price to Sales | 2.34 |
| Price to Cash Flow | 279.51 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|